The newly released "China Neuro-Interventional Device Market Size, Growth and Forecast 2025–2032" report by ResearchAndMarkets.com offers a comprehensive and data-driven analysis of one of the fastest-growing medical device sectors in Asia. Valued at USD 2.7 billion in 2024 and projected to reach USD 10.2 billion by 2032, the market is expected to grow at a robust CAGR of 18%. This in-depth report investigates the dynamics driving such rapid expansion, including the increasing prevalence of neurological disorders, technological advancements in minimally invasive procedures, growing awareness among clinicians, and significant investments in R&D and hospital infrastructure across China.
Covering both quantitative and qualitative aspects, the report presents detailed forecasts, volume analysis, and market segmentation by procedure type, stroke type, and device category. It includes coverage of 12 key neuro-interventional devices—such as stent retrievers, aspiration catheters, embolic coils, and flow diverter stents—along with volume and penetration rate forecasts through 2032. The study also features granular insights into ischemic stroke, hemorrhagic stroke, and intracranial stenosis procedures. Key strategic frameworks such as SWOT analysis and Porter’s Five Forces are included, and critical market questions are addressed—ranging from device adoption trends and clinical procedure volumes to competitive positioning and reimbursement dynamics.
This comprehensive analysis not only serves as an essential guide for industry stakeholders, investors, and policy makers but also highlights the transformative impact of neuro-interventional technologies on clinical care and patient outcomes. The report emphasizes the role of leading domestic players like Peijia Medical Technology, HeMo Bioengineering, MicroPort NeuroTech, and Zylox-Tonbridge in shaping the innovation landscape. With the healthcare system facing rising demand for minimally invasive solutions, the findings reinforce the importance of continued investment and cross-sector collaboration to improve access, reduce stroke-related morbidity, and support precision-driven neurosurgical interventions across China’s healthcare ecosystem.
MedTech Spectrum's Summary
Strong Market Growth Forecast: The China neuro-interventional device market is projected to grow from USD 2.7 billion in 2024 to approximately USD 10.2 billion by 2032, driven by rising neurological disease prevalence, technological advancements, and increasing adoption of minimally invasive procedures.
Comprehensive Market Analysis: The report provides an in-depth review of 12 key device categories, detailed segmentation by stroke type and procedure, volume and penetration forecasts, and strategic evaluations through SWOT and Porter’s Five Forces analyses.
Strategic Industry Impact: With contributions from leading domestic players like Peijia, HeMo, MicroPort, and Zylox-Tonbridge, the report emphasizes how innovation, infrastructure development, and evolving clinical needs are shaping a highly competitive and rapidly expanding neuro-interventional landscape in China.
